HC Wainwright Reiterates Buy Rating for MoonLake Immunotherapeutics (NASDAQ:MLTX)
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research report issued to clients and investors on Thursday,Benzinga reports. They currently have a $100.00 target price on the stock. HC Wainwright’s price objective points to a potential upside of 139.46% from the company’s previous […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research report issued to clients and investors on Thursday,Benzinga reports. They currently have a $100.00 target price on the stock. HC Wainwright’s price objective points to a potential upside of 139.46% from the company’s previous […]
